Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$7,755,796
+$1,176,941 QoQ
Shares Held
30,821
+1.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#1,046
of 4,152 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Columbus Macro, LLC holds $32,705,466 across 7 Drug Manufacturers - General names. ABBV ranks #2 (23.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
35,867 | $9,109,141 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
30,821 | $7,755,796 | |
| 3 | AMGN |
Amgen Inc
|
20,153 | $7,297,804 | |
| 4 | AZN |
Astrazeneca PLC
|
15,923 | $3,019,319 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,700 | $2,741,578 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,034 | $2,421,999 | |
| 7 | LLY |
ELI LILLY & Co
|
300 | $359,829 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,755,796 | 30,821 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $6,578,855 | 30,249 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $6,689,730 | 29,278 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $6,720,680 | 29,026 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $5,164,505 | 27,823 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $5,470,986 | 26,112 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $7,619,953 | 42,881 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,637,740 | 13,357 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,373,493 | 13,838 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,584,909 | 14,195 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,364,067 | 15,255 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,289,412 | 15,359 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $2,142,341 | 15,901 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $2,400,749 | 15,064 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $2,419,786 | 14,973 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,030,060 | 15,126 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $2,368,466 | 15,464 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,045,828 | 12,620 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,641,318 | 12,122 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $249,287 | 2,311 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $263,239 | 2,337 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $256,156 | 2,367 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $316,521 | 2,954 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $292,287 | 3,337 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $576,316 | 5,870 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $619,958 | 8,137 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||